shortagewatch

Home / Companies / Biomed

Company family

Biomed: medicine shortages

As of 2 Nov 2026, 64 Biomed products have a reported shortage across 1 countries, covering 21 medicines.

Products short64rank #30 of 464
Medicines21active ingredients
Countries1/16
New in 90 days00 vs market pace
Typical duration12.0 yearsmedian so far
Manufacturing9%demand-driven 5%

Where

Canada64

Which therapeutic classes

Nervous system39Cardiovascular system18Digestive tract and metabolism4Anti-infectives2Cancer and immune system1

Why, compared with all companies

Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
BiomedBiomed: Manufacturing problem 6 (9%)9%Biomed: Increased demand 3 (5%)5%Biomed: Distribution or logistics 15 (23%)23%Biomed: Other 40 (62%)62%All companiesAll companies: Manufacturing problem 4,893 (36%)36%All companies: Increased demand 1,873 (14%)14%All companies: Active ingredient shortage 367 (3%)All companies: Distribution or logistics 336 (2%)All companies: Commercial decision or withdrawal 435 (3%)All companies: Regulatory or licensing 131 (1%)All companies: Other 1,244 (9%)9%All companies: Not stated 4,221 (31%)31%

Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.

When its current shortages began

00001Dec: 0Jan ’25: 0Feb: 0FebMar: 0Apr: 0May: 0MayJun: 0Jul: 0Aug: 0AugSep: 0Oct: 0Nov: 0NovDec: 0Jan ’26: 0Feb: 0FebMar: 0Apr: 0May: 0MayJun: 0Jul: 0Aug: 0AugSep: 0Oct: 0Nov: 0Nov

Long-run trend in Canada

Canada dashboard
0122537502017: 9920172018: 363620182019: 313120192020: 121220202021: 4420212024: 662024

Canada publishes every report since 2017, so it shows whether this company is reporting more or fewer shortages over time. The current year is partial.

Against its peers

Viatris995Teva903Sandoz599Pfizer491Accord (Intas)484Stada349Zentiva340Fresenius Kabi339Apotex326Sun Pharma250Aurobindo226Towa (Pensa)201Krka187Sanofi158Biomed64

Breadth vs depth

1101001,00010,0001101001,000Products short (log scale)Medicines affected (log scale)Viatris: 995 / 248ViatrisTeva: 903 / 289TevaSandoz: 599 / 198SandozPfizer: 491 / 122PfizerAccord (Intas): 484 / 151Accord (Intas)Stada: 349 / 140Zentiva: 340 / 159ZentivaFresenius Kabi: 339 / 81Apotex: 326 / 152Sun Pharma: 250 / 77Aurobindo: 226 / 111Towa (Pensa): 201 / 102Krka: 187 / 67Sanofi: 158 / 45Jamp: 151 / 74Baxter: 149 / 27Sawai: 148 / 68Hikma: 126 / 44Glenmark: 105 / 39Sanis: 98 / 54Cheplapharm: 86 / 28GSK: 85 / 38Advanz (Amdipharm): 81 / 24Nichi-Iko: 77 / 29Takeda: 76 / 10Johnson & Johnson: 75 / 19Neuraxpharm: 75 / 19Novartis: 70 / 32Bayer: 68 / 17Daiichi Sankyo: 59 / 18Orifarm: 59 / 40Medochemie: 56 / 14Pharmascience: 51 / 32Marcan: 51 / 16Doc Generici: 50 / 25B. Braun: 49 / 17AA Pharma: 46 / 26H E: 46 / 15Octapharma: 42 / 6Jv E: 42 / 1Kyowa Pharmaceutical: 42 / 16Novo Nordisk: 41 / 8Odan: 41 / 31Aspen: 41 / 13Sterop: 41 / 16Nipro: 41 / 17Dr. Reddy's: 40 / 24Organon: 40 / 20Laboratoire Riva: 40 / 23Kern Pharma: 40 / 30Bausch Health: 39 / 30Bracco: 38 / 6G.L.: 38 / 13Tatsumi Kagaku: 38 / 24Otsuka: 37 / 4Eli Lilly: 37 / 12Piramal Critical: 35 / 13Imuna Pharm: 35 / 4AbbVie: 34 / 15Medical Valley: 34 / 8Orion: 34 / 24Rowex: 34 / 19Takata Pharmaceutical: 33 / 17Aristo: 32 / 16Norgine: 32 / 3Gedeon Richter: 31 / 11Eql: 31 / 9Guerbet: 30 / 5Lukas Heil-Betriebsst: 30 / 0Roche: 29 / 14Omega: 29 / 18Bgp: 29 / 18Holsten -: 29 / 3Menarini: 29 / 17Paladin: 28 / 17Grifols: 28 / 9Ge: 28 / 6Merck & Co. (MSD): 27 / 14Ferring: 27 / 7Biomed: 64 / 21Biomed

Further right: more products short. Higher: more different medicines affected.

Medicines short

MedicineWhere this company is shortProductsEarliest startMain reasonShort anywhere
Oxazepam927 Feb 2012Other2/16
Amitriptyline720 Apr 2011Other5/16
Flurazepam630 May 2012Other3/16
Hydrochlorothiazide623 Oct 2014Other3/16
Citalopram429 Aug 2018Distribution or logistics5/16
Gabapentin44 Nov 2020Distribution or logistics9/16
Atenolol31 Jan 2015Other6/16
Diazepam327 Feb 2012Other7/16
Irbesartan317 Sep 2018Distribution or logistics6/16
Levetiracetam31 Apr 2018Distribution or logistics9/16
Losartan318 Feb 2019Distribution or logistics6/16
Potassium Chloride323 Oct 2014Other5/16
Furosemide21 Oct 2015Manufacturing problem11/16
Anastrozole11 Jan 2019Other5/16
Carbamazepine122 Oct 2014Other5/16
Modafinil11 Apr 2017Distribution or logistics2/16
Moxifloxacin130 Nov 2020Distribution or logistics8/16
Omeprazole117 Oct 2024Manufacturing problem8/16
Quetiapine131 Mar 2020Manufacturing problem12/16
Telmisartan121 Nov 2024Other6/16
Valaciclovir115 Dec 2016Distribution or logistics10/16

Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.